non responders to semaglutide responder Not every patient responds the same to GLP-1 therapy. In the Sema Non-Responder: Change to Tirz – When Weight-Loss Drugs Don't Work

Agents Associated with Weight Gain Sulfonylureas Increase insulin secretion regardless of glycemia, typically resulting in 23 kg weight gain [44]

Result: they get half the intended dose

In clinical trials, Mounjaro produced a higher average weight loss than the 2.4 mg dose of Wegovy

The effects of magnesium, l-carnitine, and concurrent magnesiuml-carnitine supplementation in migraine prophylaxis

On days when eating feels impossible, use liquid protein

Mike Haney: So the clinical indication, as I understand it, for getting one of these drugs for the purpose of obesity is a BMI of 30, or a BMI of 27 with another condition like diabetes